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ABSTRACT 
BETSY P. HUMPHREYS:  The Role of Developmental Screening Practices in Early 
Diagnosis of Autism Spectrum Disorders: An Analysis of All-Payer Claims Data in New 
Hampshire 
(Under the direction of Samuel L. Odom, Ph.D.) 
 
Universal developmental screening during pediatric well child care detects early 
delays in development and is a critical gateway to early intervention for young children at 
risk for Autism Spectrum Disorders (ASD).  Developmental screening practices are highly 
variable, and few studies have examined screening utilization for children at risk for ASD.  
Currently, a two to four year gap exists between first recognition of concern and referral for 
diagnostic evaluation of ASD.  The purpose of the current study was to examine the 
influence of developmental screening practices on timing of ASD diagnoses in the state of 
New Hampshire through health care administrative claims data from the New Hampshire 
Comprehensive Health Care Information System. The study examined differences in mean 
age of ASD diagnosis for a sample of 144 children who were born between January 2007 and 
December 2010 who received or did not receive universal screening during well child care, 
as well as those who received screening at multiple time points and those who received 
screening at one time point.  Further, the study examined the association between gender, 
geographic region and provider type on age at diagnosis of ASD.  The data suggested no 
significant differences in mean age of ASD diagnosis for children who received a 
standardized developmental screening during well-child care and those who did not.  
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Statistically significant differences in mean age of diagnosis were found between children 
who were screened at one time point and children who were screened at more than one time 
point.  Children screened at more than one time point were diagnosed later than those 
screened at one time point.  Geographic region was a significant predictor on age of ASD 
diagnosis accounting for approximately 31% of the variance.  Continued efforts to measure 
screening practices through use of administrative claims data may increase utilization and 
improve access to intervention for young children at risk for ASD.    
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CHAPTER 1 
Autism spectrum disorder1 (ASD) is a neurodevelopmental disorder characterized by 
differences in social interaction, communication, and repetitive and stereotyped patterns of 
behavior (Diagnostic and Statistical Manual of Mental Disorders-IV-TR; American 
Psychiatric Association, 2000).  ASD is a heterogeneous disorder disrupting development 
across multiple domains at different rates during the first two to three years of life (Dawson, 
2008; Rogers, 2009; Tager-Flusberg, 2010).  Once considered a rare disorder, ASD is now 
considered the fastest growing developmental disability in the United States.  Recent 
prevalence estimates suggest 1 in 110 children are affected by the disorder (Van Naarden, K. 
et al., 2007) with males diagnosed four times more frequently than females (Fombonne, 
2009).  At the present growth rate, the cost to society in the next decade is estimated at $200-
400 billion annually.  However, with early diagnosis and intervention these costs may be 
reduced by as much as two-thirds (Ganz, 2007).   
To date there are no biological markers for identification of ASD.  However, early 
expression of ASD includes the gradual loss of typical social and communication behaviors, 
as well as the gradual emergence of atypical ones (Colgan et al., 2006; Ozonoff et al., 2010).   
Developmental differences, not evident at six months of age, may appear gradually between 
nine and twelve months of age with distinct behavioral markers of ASD observable by twelve 
months (Baranek, 1999; Brian et al., 2008; Bryson et al., 2007; Colgan et al., 2006; Landa, 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  The term Autism Spectrum Disorder (ASD) will be used throughout this paper to describe Autistic Disorder, 
Asperger’s Disorder and Pervasive Development Disorder-Not Otherwise Specified. 
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Holman, & Garrett-Mayer, 2007; Maestro et al., 2005; Osterling & Dawson 1994; Osterling, 
Dawson & Munson, 2002; Ozonoff et al., 2008; Ozonoff et al., 2010; Zwaigenbaum, 2005).                   
Infancy and early childhood are sensitive periods for intervention; some scholars 
suggest that intervention during this period may prevent full expression of a mental health 
disorder (Fonagy, 1996; Dawson, 2008).  For young children with ASD, early and intensive 
behavioral intervention has the potential to significantly improve outcomes in IQ and 
adaptive functioning (Dawson et al., 2010; Kasari, Freeman, & Paparella, 2006; McGee, 
Morrier & Daly, 1999; Reichow, 2012; Warren et al., 2011; Woods & Wetherby, 2003).  The 
prevalence of developmental disabilities in children (3-17 years) in the United States is 
estimated to be over 15%; however, the Annual Report to Congress (2008) indicated that less 
than half of children ages 3-to-5 received early childhood special education.  The pathway 
from early detection of developmental risk to early intervention is a protracted one, which 
requires the coordinated efforts of professionals from multiple disciplines and service sectors 
over a period of years.   
Most pathways include a combination of the following activities: early developmental 
screening and detection of risk factors, referral from primary care, early intervention 
eligibility evaluation, and diagnostic evaluation (Volkmar, Cook, Pomeroy, Realmuto, & 
Tanguay, 1999; Filipek et al., 2000; National Research Council, 2001; Zwaigenbaum 2009; 
Lord & Bishop, 2010).  The combination and coordination of activities that is typically 
required delays children from receiving the long-term benefits of early intervention during a 
critical period in their development.   
Parents are often the first to recognize concerns about their infants during the first 12-
18 months of life (DeGiacomo & Fombonne, 1997; Ozonoff et al., 2009; Rosenberg et al, 
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2011).  However despite parent recognition of early warning signs, and emerging evidence 
that ASD can be reliably diagnosed between two and three years of age (Charwarska, Klin, 
Paul, Macari & Volkmar, 2009; Lord et al., 2006; Risi et al., 2006), the mean age of 
diagnosis continues to be between five and six years (Mandell et al., 2010; Shattuck et al., 
2009).  Factors influencing age at diagnosis may include gender, race, socioeconomic status 
(Fountain, King & Bearman, 2010; Shattuck et al., 2009; Mandell et al., 2009), access to 
health care, geographic location, and type of ASD diagnosis (Rosenberg et al., 2011).  This 
results in a two to four-year gap between recognition of early behavioral markers and 
diagnosis of ASD.   
In the past decade, the prospects of identifying infants and toddlers at risk for ASD 
and providing early and intensive intervention have improved.  Public health awareness 
campaigns such as the Centers for Disease Control and Prevention’s Learn the Signs Act 
Early Campaign (Centers for Disease Control and Prevention, 2012) have successfully 
promoted primary and secondary prevention measures for young children with ASD.  
Practice parameters for the identification, diagnosis and care of young children with ASD in 
primary care, neurology and psychology (Volkmar et al., 1999; Filipek et al., 2000; Johnson 
& Myers, 2007) have been developed and are widely used across disciplines.  Concurrently, 
due to the persistent efforts of early childhood professionals and researchers, an evidence-
base for early and intensive behavioral intervention for children with ASD has begun to 
emerge (Dawson et al., 2010; Reichow, 2012).  These represent important first steps toward 
early identification of the disorder.  However, continuing to improve early identification of 
young children at risk for ASD will require better coordination among primary care, 
specialists in neurology and psychology, and early childhood professionals.   
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Pediatric primary health care plays an important role in the identification of young 
children at risk for ASD.  Throughout the past decade, the role of the pediatric provider2 in 
screening for developmental delays, including ASD, has been the source of a great deal of 
attention. Pediatric providers are scheduled to see young children at frequent intervals 
through the first 3 years and have the capacity to promptly identify potential problems or  
delays in child development. Further, pediatric primary care guidelines recommend the use of 
some type of standardized developmental screening instruments and ASD-specific screening 
instruments at specific ages.  Young children at risk for ASD are likely to experience early 
delays in one or more domains of development (Charwaska, Klin, Paul & Volkmar, 2007; 
Fombonne, 2005) and the consistent use of standardized developmental screening tools has 
the potential to accelerate the path to intervention for this population.   
Numerous barriers to the implementation of general and ASD-specific screening 
guidelines have been identified, which influence the timing of ASD diagnoses and access to 
educational and health care services (Mandell et al., 2010; Shattuck et al., 2009).  Pediatric 
care providers cite time constraints (Jarbrink & Knapp, 2001; Schor, 2004; Dosreis, Weiner, 
Johnson & Newschaffer, 2006), discomfort making a formal referral for autism (Jacobsen & 
Mulick, 2000), limited reimbursement for screening visits (Schor, 2004; King et al., 2005; 
Golnick, Ireland & Borowsky, 2009), a lack of familiarity with screening tools (Dosreis et al., 
2006; Tanner, Stein, Olson, Frintner & Radecki, 2009), and inadequate training in child 
development (Schor, 2004) as reasons for not following the recommended screening 
guidelines.  Some providers fear labeling a child too early (Happe & Frith, 1991) and cite 
inadequate referral sources (Tanner et al., 2009).  Other barriers to screening are related to 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2	  The term pediatric provider will be used throughout this paper to refer to pediatricians, family practice 
physicians, pediatric nurse practitioners and pediatric physician assistants.	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such factors as race, ethnicity, socioeconomic status and geographic region, which are 
reflected in timing of ASD diagnoses and access to educational and health care services 
(Mandell et al., 2010; Shattuck et al., 2009).  Improving the utilization of standardized 
developmental screening tools during the early years requires a comprehensive understanding 
of practice guidelines in pediatric primary care and an examination of system and practice 
barriers affecting families, health care providers, and early intervention professionals.   
The current study examined the influence of developmental screening practices on 
timing of ASD diagnoses for young children in the state of New Hampshire through health 
care administrative claims data from the New Hampshire Comprehensive Health Care 
Information System.  To provide background for understanding the methods and results of 
the investigation, an overview of current universal, ASD-specific, and mental health 
screening guidelines and practices in pediatric primary care are described followed by key 
demographic information and other characteristics of the state of New Hampshire.  Barriers 
associated with recommended practices, as well as the practical and ethical implications of 
early diagnosis from the perspectives of parents and providers are then described. 
Guidelines for Early Detection of Developmental and Behavioral Disorders 
The expectation that pediatric primary care providers screen for a range of 
developmental and behavioral disorders has increased significantly in the past decade. Since 
2006 the American Academy of Pediatrics (AAP) has published three sets of practice 
guidelines for early detection of developmental and behavioral disorders (birth to 5 years). 
These include universal developmental surveillance and screening (AAP Council on Children 
with Disabilities, 2006), ASD-specific surveillance and screening (Gupta et al., 2007; 
Johnson & Myers, 2007), and social-emotional surveillance and screening (Foy & AAP Task 
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Force, 2010).  Yet, few studies have examined these guidelines and the implications of their 
use for young children at risk for ASD.  
The American Academy of Pediatrics (AAP) Recommendations for Preventive 
Pediatric Health Care (AAP, 2008) suggest six routine well-child visits for children birth to 
one year, and four visits during the second year.  Beginning at age two well-child visits occur 
annually.  Comprehensive health evaluation during well-child visits includes taking history, 
growth measurements, screening vision and hearing, immunizations, laboratory screening 
processes (e.g., newborn metabolic, lead, tuberculin) and developmental/behavioral 
assessment (AAP, 2008).   
Universal Surveillance and Screening 
Routine developmental surveillance has historically been a part of pediatric 
preventive care.  However in 2006, the American Academy of Pediatrics (AAP) expanded 
their developmental surveillance and screening guidelines, identified crucial components of 
surveillance, and recommended that surveillance be conducted at every well-child visit (AAP, 
2006).  Universal developmental surveillance is now defined as a “longitudinal, continuous 
and cumulative process” (AAP, 2006, p. 407) used to identify children at risk for 
developmental delays and disabilities.   
 Guidelines identify five distinct components of surveillance that should occur prior to 
or during well-child care.  These include: (a) eliciting and attending to parents’ concerns, (b) 
probing age-appropriate skills in each domain through parent report and observation of the 
child, (c) maintaining a developmental history, (d) identifying risk and protective factors, and 
(e) documenting findings.  Developmental surveillance is a fluid and continuous process, 
highly dependent on the quality of the relationship between parent and provider, and is 
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estimated to detect 20-40% of children with developmental disabilities (Glascoe, 2000; Sand 
et al., 2005).  Immediate follow-up with a standardized developmental screening tool is 
recommended at the first sign of risk (AAP, 2006; Johnson & Myers, 2007; Gupta et al., 
2007).  Developmental surveillance is supported by developmental screening, which is a 
broad-based strategy used in well-child care. 
 The periodicity schedule for developmental screening recommends use of a 
standardized screening tool at 9-, 18-, and 30- months; however, if a 30-month visit is not 
part of the pediatric practice, then screening at 24-months is recommended (AAP, 2006).  
Young children at risk for ASD are likely to experience early delays in one or more domains 
of development (Charwaska et al., 2007; Fombonne, 2005) and 75-80% of children with 
ASD experience co-morbid behavioral or physical health disorders (Sheldrick & Perrin, 
2010).  Periodic use of standardized developmental screening instruments, paired with 
careful assessment of parents’ concerns, has the potential to assist in early detection of 
developmental and behavioral disorders and accelerate the path to intervention for young 
children at risk for ASD (Caronna, Augustyn, & Zuckerman, 2007; Glascoe, 1999; How, 
Fryer, McCarthy, Schoen & Schor, 2011; Squires, Nickel, & Eisert, 1996).   
An analysis of data from the National Survey of Children’s Health (Bethell, Reuland, 
Schor, Abrams & Halfon, 2011; N=24 million) demonstrated that the odds of a child between 
the ages of one and five years being enrolled in early intervention and having an 
Individualized Family Service Plan (IFSP) were 2.41 times more likely if an AAP-
recommended, parent-completed, standardized developmental screening tool was completed 
during well-child care.  Children under 36 months at high risk for a developmental or 
behavioral disorder were three times more likely to have an IFSP when developmental 
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screening was completed (Bethell, Reuland, Schor, Abrams & Halfon, 2011).  Thus, the 
consistent use of standardized developmental screening tools in primary care increases timely 
access to early and intensive behavioral intervention at the first sign of concern.  This is 
especially critical for young children at risk for ASD who have shown significant 
improvements in IQ and adaptive functioning when intervention occurs between 18 and 30 
months of age (Dawson et al., 2010).    
Adoption of universal screening guidelines.   National estimates suggest that 
between 50% and 75% of pediatric providers utilize standardized developmental screening 
instruments during well-child care (Arunyanart et al., 2012; Radecki, Sand-Loud, O’Connor, 
Sharp & Olson, 2011; Sand et al., 2005; Sices, Feudtner, McLaughlin, Drotar & Williams, 
2004).  Recently, the Commonwealth Fund State Scorecard on Child Health System 
Performance reported that one in five children under the age of five years received a 
developmental screening in the United States in 2007 (How et al., 2011).  A comparison of 
findings from the AAP’s Periodic Survey of Fellows suggests that the number of 
pediatricians using one or more screening tools during well-child care increased from 23% in 
2002 to over 47% in 2009 (Radecki et al., 2011).  However, approximately half of the 
pediatricians surveyed used informal checklists or documentation of parent concerns, rather 
than a standardized developmental screening instrument.  These findings are supported by 
data from the 2009-2010 National Survey of Children with Special Health Care Needs  
(n = 4,375) where sixty-three percent of parents responded that their child (12 months to 5 
years) had not received a developmental screening in the previous 12 months (described as a 
questionnaire about their child’s development, communication or social behaviors) (Data 
Resource Center for Child and Adolescent Health, 2011).  For young children at risk for 
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ASD this low utilization of standardized developmental screening instruments has critical 
implications.  More consistent utilization of standardized developmental screening tools in 
primary care could improve early identification of developmental risk factors and allow 
access to early and intensive behavioral intervention well in advance of an ASD diagnosis.     
The increased prevalence of ASD in the last decade prompted several national 
organizations to publish ASD-specific surveillance and screening guidelines for 
differentiating children who are at risk for ASD from typically developing children, and from 
those with other developmental delays and disabilities. 
ASD-specific Surveillance and Screening 
Practice parameters specifically for screening, assessment and diagnosis of ASD were 
first published by the American Academy of Child and Adolescent Psychiatry (Volkmar et 
al., 1999) and the American Academy of Neurology (AAN; Filipek et al., 1999), followed 
shortly thereafter by the guidelines for treatment of ASD in primary care by the American 
Academy of Pediatrics (AAP, Committee on Children with Disabilities, 2001).  In 2007 the 
AAP expanded and revised its ASD-specific guidelines in their clinical report entitled 
“Identification and Evaluation of Children With Autism Spectrum Disorders” and included a 
developmental surveillance and screening algorithm for pediatric well-child visits (Johnson 
& Myers, 2007).  These documents provide the foundation for current practice across the 
disciplines of psychiatry, neurology and primary care, and also assist diagnostic clinicians 
and primary care providers in identifying and providing treatment for children at risk for 
ASD.   
 Practice guidelines specify three risk factors: (a) family history of ASD, (b) parent or 
caregiver concerns about early developmental milestones, especially in the area of social 
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communication, and (c) provider concerns.  Additionally, four observable behaviors 
warranting immediate diagnostic evaluation include: (a) no babbling or pointing or other 
gestures by 12 months, (b) no single words by 16 months, (c) no two-word spontaneous 
phrases by 24 months, and (d) loss of language or social skills at any age (Filipek et al., 
1999; Gupta et al., 2007; Johnson & Myers, 2007).  Surveillance and screening guidelines 
emphasize that providers should never delay referrals for developmental evaluations and 
services if there are concerns (Johnson & Myers, 2007; Caronna et al., 2007).   
There are two approaches to ASD-specific developmental screening.  The AAP 
guidelines suggest that a population-based screen (Level 1) such as the Modified Checklist 
for Autism in Toddlers (MCHAT; Robins, Fein, Barton, & Green, 2001) be administered in 
conjunction with a universal screening to all children at 18- and 24-months, and further 
evaluation with a specialized ASD-specific screen (Level II) if initial screening is indicative 
of risk.  Referral for immediate diagnostic evaluation is recommended if initial screening is 
indicative of risk (Gupta et al., 2007; Johnson & Myers, 2007).  By contrast, the AAN 
practice parameters recommend the use of more specific Level II screens after a general 
developmental screen indicates a risk of ASD.  The AAN does not advocate the use of 
population-based (Level I) ASD screening instrument (Filipek et al, 2000).  Level II 
screening tools generally require more time to administer and more expertise on the part of 
the primary care provider to score and interpret.  These tools are typically used in specialized 
settings where children with known developmental delays are referred, such as a neurology 
clinic or early intervention agency (Bishop, Luyster, Richler & Lord, 2008; Johnson & Myers, 
2007).  Inconsistencies in AAP and AAN practice guidelines may be negatively influencing 
clinical practice in preventive pediatric care and is worthy of further investigation. 
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Adoption of ASD screening guidelines.  A number of studies have examined 
prevalence estimates across states (Center for Disease Control and Prevention, 2012; Liptak 
et al., 2008) and regional differences in identification of ASD (Mandell & Palmer, 2005). 
However, there is a significant gap in the literature on utilization of ASD-specific screening 
in primary care.  For example, a comparison of survey responses (n - unpublished) after the 
Learn the Signs Act Early Campaign was implemented in 2006 reported that pediatricians 
were more aware of resources for referral and treatment (87%), and had resources to educate 
parents (77%) (Daniel, Prue, Taylor, Thomas & Scales, 2009).  However, nearly 20% of 
pediatricians continued to employ a ‘wait and see’ approach for young children at risk for 
ASD (Daniel, Prue, Taylor, Thomas & Scales, 2009).   
Arunyanart et al. (2012) surveyed pediatricians and nurse practitioners in six states (n 
= 480) and reported unexpected disparities in access to screening practices based on 
geographic, socioeconomic and demographic factors.  In their sample, providers in urban 
settings serving high percentages of Medicaid-enrolled families were more likely to conduct 
developmental and autism-specific screenings than providers in suburban settings serving 
high percentages of privately insured, White families and lower percentages of non-White, 
Medicaid-enrolled families.  Seventy-five percent of respondents reported using a 
standardized ASD-specific screening tool.   
Other studies at the state level include a sample of 54 providers in two southern states 
(Alabama and Mississippi) who reported use of ASD-specific screens at 28% (Gillis, 2009) 
and a sample of 255 primary care physicians from the Mid-Atlantic region where only 8% of 
the physicians used ASD-specific screening tools (Dosreis et al., 2006).  Clearly, further 
study of ASD-specific screening instrument utilization in primary care is warranted. 
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Social-emotional Surveillance and Screening 
In 2010 the AAP Task Force on Mental Health published a comprehensive 
supplement on pediatric mental health (Foy & AAP Task Force, 2010).  Although this exists 
as a separate set of guidelines, the document subsumed universal and ASD-specific 
guidelines for surveillance of children under 5 years of age. The algorithm specifies 
procedures for identifying social-emotional concerns in early development and recommends 
referral for further evaluation when any of the following conditions are present: “disordered 
parent-child relationship, parental mental illness, language or communication delay 
(emphasis added), disruptive behavior with aggression, abuse or neglect of the child, and 
self-injury” (Foy & AAP Task Force, 2010; p. S119).   
Since ASD is primarily a social communication disorder it may be considered a 
social-emotional concern affecting children under five.  The addition of pediatric mental 
health guidelines may affect the adoption of ASD-specific guidelines, but to date this has not 
been examined.  A comprehensive list of AAP-recommended screening tools for pediatric 
mental health may be found in Supplemental Appendix S12 (Foy & AAP Task Force, 
Supplemental Appendix S12, 2010).  
Recommended Screening Instruments (Birth-5) 
There are a variety of standardized developmental screening instruments available for 
use in primary care practices with varying purposes, methods of administration (completed 
by parent or practitioner), estimates of sensitivity and specificity, and cost.  A sensitivity and 
specificity of no less than 80% are recommended for developmental screening of young 
children (Meisels, 1989); however this depends, in part, on the purpose of the screening and 
the age at which it occurs.  Screening tools may be designed to elicit parent concerns about a 
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child’s development globally, measure a range of developmental skill areas, or detect the 
presence of specific disorders (Drotar, Stancin, Dworkin, Sices & Wood, 2008). Practices 
and providers must consider the purposes of screening in their setting and the characteristics 
of their patient population.  Screening tools also score differently across patient populations 
and practice settings and careful consideration must be given to the characteristics of the 
patient population.  For instance, a practice setting serving many high-risk families may be 
best served by choosing a screening instrument with demonstrated sensitivity and specificity 
for that population.  The choice of a screening instrument also depends on the experience of 
the providers in that practice setting and their comfort with screening tools.  A review of the 
scientific validity of screening instruments (Drotar, Stancin, Dworkin, Sices & Wood, 2008) 
provides guidance for practices that are considering screening instruments for their setting. 
The AAP Bright Futures publication Coding for Pediatric Preventive Care 2011 
(AAP, 2011) lists AAP-recommended developmental screening instruments, including ASD-
specific instruments (Table 1.1).  Assessments marked with an asterisk are also included on 
the AAP list of recommended mental health screening tools for pediatric primary care (Foy 
& AAP Task Force, Supplemental Appendix S12, 2010) and are suitable for use with 
children 5 and under.   
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Table 1.1  
AAP-Recommended Developmental Screening Instruments 
Garnett, M. and Attwood, A. (1995).  Australian Scale for Asperger’s Syndrome (ASAS)  
*Gioia, G., Espy, K. and Isquith, P. Behavioral Rating Inventory of Executive 
Functioning (BRIEF). Florida: Psychological Assessment Resources, Inc.   
Glascoe, F.P. (1997). Parents Evaluation of Developmental Status (PEDS). Nashville, 
TN: Ellsworth and Vandemeer Press.  
 *Jellinek, M. and Murphy, J.M. Pediatric Symptom Checklist: A Primary Care 
Screening Tool to Identify Psychosocial Problems (PSC). (http://www2. 
massgeneral.org/allpsych/psc/psc_home.htm) 
*Reynolds, C.R. and Kamphaus, R.W. 2006. BASC-2: Behavior Assessment System for 
Children, Second Edition. New Jersey: American Guidance Service.  
Robins, D. L., Fein, D., Barton, M.L., & Green, J.A. (2001).  The Modified CHecklist 
for Autism in Toddlers: An initial study investigating the early detection of autism 
and pervasive developmental disorders.  Journal of Autism and Developmental 
Disorders, 31, 131-144. 
*Squires, J., Bricker, D. & Twombly, E. (2002).  Ages & Stages Questionnaire-Social 
Emotional.  Baltimore: Brookes. 
Wolraich, M. L. (1998). Vanderbilt Attention Deficit/Hyperactivity Disorder Parent 
Rating Scale 
*Assessments marked with an asterisk are also included on the AAP list of recommended mental 
health screening tools for pediatric primary care  
 
A 2010 study conducted by King et al. (2010) reported the most commonly used 
universal developmental screening instruments were the Parents Evaluation of 
Developmental Status (PEDS; Glascoe, 1997) and the Ages and Stages Questionnaire (ASQ-
SE; Squires et al., 2002) (King et al., 2010).  A more recent study across six states 
(Arunyanart et al., 2012) reported that the most common ASD-specific screening tool used in 
primary care was the Modified-Checklist for Autism in Toddlers (MCHAT; Robins et al., 
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2001).  Information about the most frequently used screening tools for pediatric mental 
health is not yet available.   
Development of universal, ASD-specific and mental health screening guidelines has 
resulted in detailed protocols for early detection of developmental and behavioral disorders in 
early childhood and the development of a wide variety of screening instruments.  However, 
assuring timely access to early intervention or diagnostic evaluation for young children at 
risk for ASD requires comprehensive study of these practices and the barriers to their 
implementation in primary care settings. 
Barriers to Screening 
Implementation of screening guidelines is a complex process requiring providers to 
evaluate the purpose(s) of screening in their practice, the characteristics of their patient 
population, the incidence of developmental disability in their practice, the resources and 
technical assistance available to implement a screening program, and the availability of 
assessment and intervention in their community (Drotar et al., 2008).  The implementation of 
both universal and ASD-specific developmental screening guidelines has been challenging 
for primary care practitioners and, across studies and years, a number of system and 
knowledge barriers have been identified.   
System barriers include time constraints (Arunyanart et al., 2012; Dosreis et al., 2006; 
Jarbrink & Knapp, 2001; Radecki et al., 2011; Schor, 2004; Tanner et al., 2009), limitations 
in reimbursement for screening visits (Golnick et al., 2009; King et al., 2005; Radecki et al., 
2011; Schor, 2004), a lack of trained non-physician office staff (Radecki et al., 2011; Schor, 
2004), and limited access to community resources (Schor, 2004).  Individually and in 
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combination these system barriers have a negative influence on the implementation of 
screening guidelines.  
Knowledge barriers also limit the implementation of the guidelines.  Knowledge 
barriers include lack of familiarity with screening tools (Dosreis et al., 2006; Radecki et al., 
2011; Tanner et al., 2009), lack of confidence in conducting developmental screening 
(Radecki et al., 2011), need for autism education (Golnick et al., 2009; Jacobsen & Mulick, 
2000), fear of labeling a child too early (Happe & Frith, 1991), identification of 
developmental risk without adequate referral sources (Tanner et al., 2009), and difficulties 
with care coordination (Golnick et al., 2009; Golnick, Scal, Wey and Gaillard, 2012). 
Some pediatric providers have criticized ASD-specific screening programs positing 
that evidence of effectiveness is scant for early ASD screening (Al-Qabandi et al., 2011; 
Williams & Brayne, 2006).  These claims are not supported by the literature and have been 
refuted by the ASD research community (Dawson, Fein, Rogers, & Zwaigenbaum, 2011); 
however they do represent the perspectives of some pediatric providers.  A closer 
examination of the social validity of ASD-specific screening guidelines is warranted and will 
inform future implementation efforts. 
Finally, some providers have suggested that expectations for primary care may 
exceed what is feasible, and that coordination with other community resources should be 
considered in support of well-child care (Tanner et al, 2009; Golnick et al., 2012). Several 
pediatric providers, researchers and parents have proposed that well-child care be redesigned  
(Schor, 2004; Coker, Chung, Cowgill, Chen & Rodriguez, 2009; Tanner et al., 2009).  
Efforts to overcome barriers to screening.  The National Academy for State Health 
Policy partnered with the Commonwealth Fund to implement the Assuring Better Child 
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Development Screening Academy (ABCD; Kay, May & Reuland, 2009).  Nineteen states, the 
District of Columbia, and Puerto Rico participated in the ABCD Academy, which resulted in 
significant increases in developmental screening practices (an average of 58 percentage 
points) in 13 states through adoption of common policy goals, practice improvements and 
specific measurement approaches.  Significant practice improvements included (a) office-
wide systems of screening administration and (b) implementation of specific measurement 
approaches.  Member states developed individualized approaches to measure rates of 
screening and identify sources of data.  Fourteen of the 21 states/territories used medical 
records, four states used claims data, three states used parent surveys, and four states used 
multiple sources of data to measure the rate of developmental screening (Kay, May & 
Reuland, 2009).   
ABCD member-state North Carolina implemented the North Carolina Assuring Better 
Child Health and Development project (Earls & Hay, 2006).  In the year 2000 the project 
piloted a process for assisting pediatric offices with implementation of developmental 
screening to promote early identification and links to referral.  The process was replicated in 
nine counties and statewide Medicaid policy in support of developmental screening was 
passed in 2004.  In 2006 the project reported that more than 70% of Medicaid-eligible 
children in North Carolina were receiving developmental screening during well-child care 
(Earls & Hay, 2006). 
A similar study conducted by the AAP assessed the ability of a nationally 
representative sample of 17 pediatric practices in 15 states to implement recommended 
guidelines for developmental screening (King et al., 2010).  At the conclusion of the study 
nine of the 17 practices studied reported conducting developmental screening, but not 
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according to the recommended guidelines. Practices that selected parent-report screening 
tools and developed office-wide systems of administration and systematic data collection for 
screening distribution and completion were most successful at implementing the AAP 
guidelines (King et al., 2010).    
Van Cleave et al. (2012) conducted a systematic review of the evidence for office-
based interventions to increase recommended screening services in pediatric primary care.   
Developmental and ASD-specific screenings were among many recommended screening 
processes examined.  Out of 2,457 articles, 23 met inclusion criteria for the systematic 
review process.  Although findings from this study were inconclusive, the authors noted that 
elements of successful screening interventions utilized combinations of collaborative 
learning methods, office-wide system improvements, and systematic data collection (Van 
Cleave et al., 2012). 
Successful screening initiatives include those that have implemented office 
improvements and measured screening practices at the state level through cross-agency and 
cross-sector partnerships and use of administrative claims data (Kay et al., 2009; King et al., 
2010; Van Cleave et al., 2012).  However, developmental screening practices are 
idiosyncratic and variable across states, populations and geographic regions (How et al., 
2011).  As economic resources dwindle it becomes critical for states to build on what has 
been learned in the last decade about supporting effective implementation of developmental 
screening in primary care (Honigfield, Chandhok, Spiegelman, 2012).  Increasing access to 
early screening is a critical step towards accelerating early detection of ASD and providing 
access to early intervention.   
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Critical Questions 
The quest to understand and improve screening for ASD and provide timely access to 
services has resulted in a number of critical questions that are emerging across the literature 
in pediatrics, in the ASD research community, and among early childhood practitioners and 
families.  These questions reflect our collective understanding of child development and 
issues related to measurement within this population.  
Expression of Developmental Disability in Early Childhood 
A central question concerns the wide variability in expression of developmental 
delays and disability in young children (Dietz, Swinkels, van Dalen, van Engelend & 
Buitelaar, 2006; Pandey et al., 2008, Sices, 2010) and the potential for overlap and/or co-
morbidity of developmental disorders during this period (Levy et al., 2010; Sheldrick & 
Perrin, 2010).  In a narrative review of over 250 articles related to developmental 
surveillance and screening for children birth to age five, Marks, Glascoe and Macias (2011) 
reported wide variation in the progression of disorders in children prior to diagnosis of a 
developmental delay or disability.  They raised questions about the expression of 
developmental delays and disabilities in early childhood .   
A recent study utilized cross-sectional analyses of data from the National Survey of 
Children’s Health to examine services for children with four behavioral health conditions, 
including ASD (Sheldrick & Perrin, 2010).  Findings suggest that 75 to 80 percent of 
children with ASD have co-morbid behavioral disorders.  High rates of co-morbidity in 
young children at risk for ASD complicates differentiating early developmental delays from 
early markers of ASD or other neurodevelopmental disabilities (Yirmiya & Charman, 2010).  
Although researchers have begun to identify risk factors and early behavioral markers of 
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ASD, there continues to be uncertainty about the varied early developmental trajectories of 
ASD as it emerges in young children.  This has critical implications for children at risk for 
ASD and requires further study.   
Sensitivity and Specificity of Developmental Screening Instruments 
Another set of questions concerns the ability of standardized developmental screening 
tools to differentiate children who have developmental delays from children at risk for ASD.   
The accuracy of screening instruments is measured by the psychometric properties of 
sensitivity, specificity, positive predictive value and negative predictive value.  Sensitivity 
refers to the ability of a screening instrument to correctly detect all of the children at-risk 
(true positives).  Screening instruments with high sensitivity are best suited for broad 
developmental screening programs, but may result in over-identification of children at risk 
and place a burden on over-taxed systems of care.  Specificity refers to the ability of an 
instrument to correctly detect all of the children who are not at risk (true negatives).  An 
instrument with poor specificity may result in over-identification of children who do not have 
ASD, with implications for families and systems of care.  Adjustments to the sensitivity of an 
instrument will affect the specificity of that instrument, and vice versa.  A sensitivity and 
specificity of no less than 80% are recommended for developmental screening of young 
children (Meisels, 1989).  Positive predictive value (PPV) refers to the ability of a screening 
instrument to correctly determine the proportion of test results that are true positives.  
Conversely, negative predictive value (NPV) measures the proportion of test results that are 
true negatives.  In the case of ASD-specific screening, PPV may be considered more 
important than sensitivity as providers want to ensure that a high-risk screens indicates high 
likelihood of the child developing ASD (Baranek, personal communication, 2012).  The 
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purpose of the screening and the age at which it occurs will determine which psychometric 
properties are best considered.   
Broadband Developmental Screening Tools.  Several studies have examined the 
extent of broadband developmental screening tools to differentiate young children at risk for 
developmental delays from children at risk for ASD.  The Parents Evaluation of 
Developmental Status (PEDS; Glascoe, 1997) and the M-CHAT (M-CHAT; Robins et al., 
2001) were administered to152 children concurrently to determine the clinical utility of the 
AAP-recommended guidelines (Pinto-Martin et al., 2008).  Fourteen percent of the children 
(n=114) who passed the screening for developmental concerns on the PEDS screened 
positive for ASD concerns on the M-CHAT suggesting that the PEDS was not sensitive 
enough to detect risk of ASD (Pinto-Martin et al., 2008). 
The Infant-Toddler Checklist (ITC; Wetherby & Prizant, 2002) a component of the 
Communication and Symbolic Behavior Scales-Developmental Profile (CSBS-DP; Wetherby 
& Prizant, 2002) was designed as a broadband screening instrument to detect communication 
delays in children ages 6-24 months.  Recent findings suggest that the sensitivity of the 
CSBS-DP-ITC is 0.91 in children under 24 months (Oosterling et al., 2009) and it is showing 
promise as a screening tool for detecting young children at risk for ASD (Pierce et al. 2011).  
With increased interest in earlier identification of ASD, the development of ASD-specific 
screening instruments has become a research priority (Charwaska et al., 2007; Dietz et al., 
2006; Kleinman et al., 2008; Pandey et al., 2008; Robins & Dumont-Mathieu, 2006; Watson 
et al., 2007).   
ASD-specific Screening Tools.  The Modified-Checklist for Autism in Toddlers 
(MCHAT; Robins et al., 2001) is a 23-item parent-report screening tool used to detect ASD 
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in children 16-30 months, with a PPV of 0.11 (Robins & Dumont-Mathieu, 2006). The PPV 
of the M-CHAT increases to 0.65 when accompanied by a follow-up interview with a 
caregiver (Kleinman et al., 2008). The true sensitivity and specificity of the M-CHAT are still 
unknown, and a high rate of false positives has been reported.  To reduce the occurrence of 
false positives the M-CHAT should only be used with the follow-up interview (Wetherby, 
Brosnan-Maddox, Peace & Newton, 2008).  For these reasons, researchers emphasize that 
providers should be cautious about making definitive statements about ASD.   
The First Year Inventory (FYI; Reznick et al., 2003), while not yet available for 
clinical use, is the only parent-report population-based screening tool being developed to 
detect risk for ASD in children as young as 12 months.  A retrospective pilot study exploring 
the face validity of the FYI reported that it successfully discriminated 12-month olds who 
were later diagnosed with ASD from typically developing and developmentally delayed 
children (Watson et al., 2007). In a recent 3-year follow up study the FYI correctly identified 
77% of 12-month olds with developmental delays and disabilities. Further, 44% of the 12-
month olds who initially screened positive on the FYI were diagnosed with ASD by age 3 
(Turner-Brown, Baranek, Reznick, Watson & Crais, 2012).  Further investigation of the 
FYI’s clinical utility and psychometric properties are underway, and it shows promise as an 
ASD-specific screening tool.   
Researchers and clinicians have posed numerous practical and ethical concerns about 
early screening for ASD.  Across studies, there is considerable variability in estimates of 
sensitivity and specificity of existing ASD-specific screening instruments.  The psychometric 
properties of these tools, and optimal ages for screening are being studied extensively, 
existing instruments are being revised, and new ones are being developed.  Further empirical 
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and clinical evaluation of the use of these tools for various purposes is critical, and for those 
using these instruments with young children, screening results must be interpreted with 
caution (Barton et al., 2011; Johnson & Myers, 2007; Wetherby et al., 2008; Yirmiya & 
Charman, 2012).   
Talking With Parents about ASD 
Providers frequently cite apprehension about raising a question of ASD in the absence 
of a diagnosis (Kleinman et al., 2008).  Some providers prefer to engage in a period of 
‘watchful waiting’ before discussing the possibility of ASD (Caronna et al., 2007; Ozonoff, 
2009), while others prefer to raise concerns about ASD immediately and assist parents and 
caregivers in making informed decisions about intervention in the absence of an ASD 
diagnosis (Brian et al., 2008).   
In a recent focus group study conducted at the University of North Carolina at Chapel 
Hill (Crais et al., 2010; unpublished raw data), parents were asked to share their views of 
screening for ASD at the 12-month well-child visit, particularly as the process related to 
concerns about their child, the kinds of information they were seeking, and how they felt 
about healthcare providers screening for developmental issues, including ASD.  Three focus 
groups were held with 21 parents whose children had recently had a 12-month well child 
visit.  Parents expressed a range of perspectives about ASD screening.  Some parents were 
open to screening for ASD and the chance to “catch it early,” especially if there were 
concrete intervention steps they could take.  However, if the risk of ASD was shared and 
parents were left without guidance, several parents stated they would prefer not to complete 
the screening.  Other parents had questions about how definitive a screening at 12 months 
could be and were concerned that use of an ASD-specific screening instrument would result 
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in a diagnosis of ASD (Crais et al., 2010; unpublished raw data).  Continued study of the 
social validity of screening practices with parents and providers is warranted. 
Alignment of Practice Guidelines 
 Marks et al. (2011) point to the number of practice guidelines for detection of early 
developmental and behavioral problems and call for a revision of the 2006 and 2007 AAP 
guidelines to better align with the 2010 AAP algorithm.  They re-conceptualized 
developmental surveillance from “longitudinal, continuous, and cumulative” (AAP, 2006, p. 
407) to “flexible, longitudinal, continuous, and cumulative process with multiple action steps 
and decision-making points” (emphasis added; Marks et al., 2011, p. 10).  Recommendations 
for universal surveillance and screening include (1) investigating the categories of universal 
screening measures (e.g., developmental, ASD and social-emotional) as well as the optimal 
timing and periodicity of those measures, (2) continued research on the sensitivity and 
specificity of universal screening measures and their ability to detect ASD, (3) prescreening 
with psychometrically sound instruments, (5) defining clear referral thresholds for clinicians, 
(6) ongoing promotion and monitoring of developmental-behavioral wellness in primary care, 
and (7) a post-screening process to ensure that high risk children access further evaluation 
and services.   
Despite the questions, concerns, and ongoing dialogue associated with screening for 
developmental and behavioral disorders in early childhood much progress has been made in 
the last decade. Strong evidence suggests that young children at risk for ASD have 
experienced improved access to early intervention and early diagnosis when standardized 
developmental screening is completed during well-child care.   
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Summary 
 Previous research suggests that early behavioral markers of ASD may appear between 
9 and 12 months of age (Baranek, 1999; Brian et al., 2008; Bryson et al., 2007; Colgan et al., 
2006; Landa et al., 2007; Maestro et al., 2005; Osterling & Dawson 1994; Osterling et al., 
2002; Ozonoff et al., 2008; Ozonoff et al., 2010; Zwaigenbaum, 2005) and that early and 
intensive behavioral intervention significantly improves developmental outcomes for 
children with ASD (Dawson et al., 2010; Kasari et al., 2006; McGee et al., 1999; Reichow, 
2011; Warren et al., 2011; Woods & Wetherby, 2003). Yet, the period between recognition of 
concern and referral for early intervention or diagnostic evaluation can be as long as four 
years with a mean age of diagnosis between 5 and 6 years of age (Mandell et al., 2010; 
Shattuck, 2009).  Racial and ethnic disparities may result in even later diagnoses (Fountain et 
al., 2010; Shattuck et al., 2009; Mandell et al., 2009, Rosenberg et al., 2011).  Children with 
ASD often have co-morbid developmental delays, which early screening may detect well 
before a diagnosis of ASD is made (Bethell et al., 2011); therefore, universal screening 
during well-child care is critical for young children at risk for ASD.  States that have been 
successful at implementing and sustaining developmental screening initiatives have 
examined and measured screening practices through cross-agency partnerships and use of 
administrative claims data (Kay et al., 2009); however, continued efforts to understand 
access to screening in specific regions of the country are warranted.  To provide context for 
understanding the methods and results of the current study, key demographic information and 
other characteristics of the state of New Hampshire will be described.   
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New Hampshire 
Demographics 
New Hampshire is a small New England state (8,953 square miles)	  with an estimated 
population of just over 1 million people.  Twenty-one percent of the population (~210,000) is 
aged birth to 18 and five percent of the population (~50,000) is aged birth to five years (US 
Census Bureau, 2011).  The state is divided into ten counties with nearly 77% of New 
Hampshire’s population concentrated in five southern counties (Hillsborough, Rockingham, 
Merrimack, Strafford and Belknap).  For the purposes of this study a distinction was made 
between rural counties with a population less than 100,000 and urban counties with a 
population greater than 100,000 (Figure 1.1).   
Between 2006 and 2010 the median household income in New Hampshire was  
$63, 277 and approximately 8% of the population lived below the poverty line.  Ninety-one 
percent of individuals over age 25 were high school graduates and 31% completed a 
Bachelor’s Degree.  The state is largely white and non-Hispanic.  Eight percent of persons 
over age five speak a language other than English in the home.  More detailed information 
about racial and ethnic representation in New Hampshire is provided in Table 1.1.   
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Figure 1.1   
New Hampshire Population by County 
 
Source for population stats: United States Census Bureau, 2010.  Retrieved from 
http://quickfacts.census.gov/qfd/states/33/33001.html 
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Table 1.2  
New Hampshire Demographics 
Race % 
White 93.9   
Black   1.1     
American Indian and Alaska Native    0.2     
Asian   2.2     
Native Hawaiian and Other Pacific Islanders   0.0        
Two or more races reported   1.6 
Ethnicity  
Hispanic or Latin origin   2.8   
 
Distribution of Health Care Providers 
The Dartmouth Institute for Health Policy and Clinical Practice studied the 
distribution of pediatricians and family practice physicians caring for children in the state and 
nation (Shipman, Lan, Chang & Goodman, 2011).  Their findings suggest that New 
Hampshire has primary care service areas where there are no providers caring for children, or 
where provider caseloads exceed 3,000 children per physician.  An estimated 16.6% or 
51,150 children live in low-supply areas, which are also largely poor and rural (Shipman et 
al., 2011).  
New Hampshire Early Intervention System 
New Hampshire’s Family Centered Early Supports and Services Program (NH 
FCESS) serves children birth to three years and is administered by the NH Department of 
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Health and Human Services, Bureau of Developmental Services through 10 county-level area 
agencies.  In 2010 NH FCESS received 1918 referrals, over half of which (52%) were made 
by health care providers.  Eligibility categories in NH include: (1) a diagnosed established 
condition resulting in developmental delay, (2) atypical development documented by family 
and qualified personnel (e.g., self-injurious, sleep disturbances, chronic anxiety, aggression), 
(3) delays of 33% in one or more area of development as determined by multidisciplinary 
evaluation, and (4) child or family experiences more than 5 risk factors for substantial delay 
(e.g., birth weight, history of abuse or neglect, prenatal drug exposure, nutritional problems, 
family history of developmental disability) (NH Department of Health and Human Services, 
2011).   
Developmental Screening in New Hampshire 
In New Hampshire, a state with an estimated 66,000 children ages birth to five years 
(US Census Bureau, 2010), the Commonwealth Fund State Scorecard reported only 18.1% of 
children received a developmental screening in 2007, ranking NH 32nd in the nation on this 
indicator (How et al., 2011).  Similarly, data from the 2009-2010 National Survey of 
Children with Special Health Care Needs reported that 69% of parents had not received a 
developmental screening within the last year during their child’s well child visit (Data 
Resource Center for Child and Adolescent Health, 2011).    
 In 2009, the New Hampshire Department of Health and Human Services, Division for 
Children, Youth, and Families invested in a pilot program called Watch Me Grow, a 
developmental screening and referral initiative aimed at developing a network of screening 
providers in the state. As of this writing Watch Me Grow has been successfully implemented 
in 12 locations across the state and a total of 690 screenings have been conducted (D.J. 
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Nelson, personal communication, 2012).  Through Watch Me Grow New Hampshire’s 
Family Resource Centers train local providers from multiple disciplines to work with parents 
to complete the Ages & Stages Questionnaire-3 (ASQ; Squires et al., 2002) in a variety of 
settings.  Efforts to track screenings and monitor referrals in the state are currently underway, 
but clearly New Hampshire has invested in creating mechanisms intended to increase access 
to early screening and diagnosis. 
New Hampshire Autism Registry 	  	   New Hampshire has also invested in documenting new cases of ASD in the state.	  	  In 
November 2008, the New Hampshire Department of Health and Human Services 
implemented the first state autism registry in the country for the purpose of recording ASD 
diagnoses.  Health care providers who are qualified to make a diagnosis of autism spectrum 
disorder are required to report new cases of ASD in New Hampshire to the NH Department 
of Health and Human Services.  A total of 450 ASD diagnoses were reported in New 
Hampshire by 51 unique providers between January 2009 and December 2011 (E. Collins, 
personal communication, July 26, 2012).  To date, efforts to measure compliance with this 
reporting requirement have not been implemented and the data must be interpreted with 
caution.  Table 1.2 provides specific information regarding the ages of the children reported 
to the registry in each year. 
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Table 1.3 
New Hampshire Autism Registry Data 2009-2011(# children) 
 2009  2010 2011 
< 2 years 4 8 9  
2 years 47 32 44 
3-8 years 73 74 64 
>8 years 28 43 24 
Total 152 157 131 
Mean age in months 38 39.25 32.75 
 
New Hampshire’s developmental screening initiative and autism registry are 
important first steps towards improving the rate of developmental screening in the state and 
documenting new cases of ASD.  One strategy employed in monitoring successful screening 
initiatives has been measurement of screening practices through use of administrative claims 
data (Kay et al., 2009).  The present study built upon this strategy. 
Purpose and Significance of the Current Study 
 The present study was designed to understand the relationship between the use of 
standardized developmental screening instruments in primary care and timing of ASD 
diagnosis by examining administrative claims data for young children who later received a 
diagnosis of ASD in New Hampshire.  Findings that clearly link earlier diagnosis to the 
utilization of developmental screening instruments may serve to increase adherence to 
screening guidelines in a profession that is guided by evidence-based practices.   
Specifically, the study addressed the following research questions: 
	   	    
 32	  
1. Are there significant differences in the mean age of ASD diagnosis for those 
children screened and those not screened for developmental issues during well-child 
visits?  
Hypothesis:  The initial hypothesis was that children who received developmental 
screening during well-child care would be diagnosed earlier than those who were not 
screened. 
2. Are there significant differences in mean age of ASD diagnosis for children who 
were screened at one time point and children who were screened at more than one 
time point for developmental issues during well-child visits? 
Hypothesis: The initial hypothesis was that children who received developmental 
screening at more than one time point would be diagnosed earlier than those who 
were screened once. 
3. What is the relative strength of the association between gender, geographic region 
or provider type and age at diagnosis of ASD?   
Hypothesis:  The initial hypothesis was that Gender would be the strongest predictor 
on age of ASD diagnosis, followed by Geographic Region and Provider Type when 
controlling for other variables in the analysis.   
  
CHAPTER 2 
Method 
The current study was designed to examine developmental screening practices in the 
state of New Hampshire using administrative claims data for young children who later 
received a diagnosis of ASD.  The purpose was to understand the relationship between the 
use of screening practices and a number of factors including the age of diagnosis of ASD.   
Data Source  
The New Hampshire Comprehensive Health Care Information System (NH-CHIS) 
was created in 2005 as a result of a NH State statute to make health care data available to 
“insurers, employers, providers, purchasers of health care, and state agencies to continuously 
review health care utilization, expenditures, and performance in New Hampshire… ” 
(Chapter 420-G: Portability, Availability, Renewability of Health Care Coverage, 2005).  
The New Hampshire Insurance Department (NHID) and the NH Department of Health and 
Human Services (NH-DHHS) partner to administer the NH-CHIS.  Health insurance carriers 
submit encrypted medical, dental and pharmacy claims and eligibility files from public and 
private payers to the state at regular intervals.  NH-CHIS contains a subset of New 
Hampshire Commercial Claims, including those from the following health insurance carriers: 
Anthem, Cigna and Harvard Pilgrim and a subset of New Hampshire Medicaid Claims data. 
The system provides unprecedented access to comprehensive health care claims data 
collected in primary care settings and provides important information on cost, quality, 
utilization and barriers to care (Love, Custer & Miller, 2010; Miller, Love, Sullivan, Porter & 
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Costello, 2010).  The data currently reside at the NH-DHHS Office of Medicaid Business and 
Policy in Concord, NH; however, the University of New Hampshire’s Institute on Health 
Policy and Practice (NHIHPP) has permission to use a limited use data file for research 
purposes and New Hampshire is one of the first states in the nation to make this type of data 
available to researchers.  The current investigation required a NH-DHHS approved limited-
use application to access the data, as well as approval by the NH-DHHS and the Institutional 
Review Boards of the University of North Carolina at Chapel Hill and the University of New 
Hampshire.   
The NH-CHIS data are robust from 2005 to the present and medical, pharmacy and 
dental claims are entered into the NH-CHIS system at 6-month intervals.  A study start date 
of January 2007 was determined in order to capture the publishing of the American Academy 
of Pediatrics ASD Screening Guidelines in October 2007.  The end date for this study was 
determined by the limited-use application, which was submitted in June 2011 and captured 
data through December 2010 resulting in a 48-month study period between January 1, 2007 
and December 30, 2010.  
Sample.  The following algorithm was utilized to extract the sample of children 
across the commercial and Medicaid data sets.  First, all individuals with ICD-9 diagnostic 
codes of 2990 Infantile Autism, 29900 Infantile Autism-Active, or 29901 Infantile Autism-
Residual (Diagnostic and Statistical Manual of Mental Disorders-IV-TR, American 
Psychiatric Association, 2000) were extracted from a subset of New Hampshire Commercial 
Claims, including those from Anthem, Cigna and Harvard Pilgrim resulting in a subset of 
1553 children with a primary or secondary diagnosis of ASD.  Children with birthdates in the 
48-month period between January 1, 2007 and December 30, 2010 were extracted from the 
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Commercial Claims resulting in 85 unique members (81% M, 19% F) with a primary or 
secondary diagnosis of ASD.  The same algorithm was applied to the New Hampshire 
Medicaid Claims data resulting in 1657 individuals with a primary or secondary diagnosis of 
ASD and 124 unique members (72% M, 28% F) with birthdates in the 48-month period 
between January 1, 2007 and December 30, 2010.   
All de-identified medical, dental and pharmacy claims and eligibility files associated 
with each unique member were included in the Commercial (n=85; 9,709 claims) and 
Medicaid (n=124; 25,248 claims) subsets of data.  For the purposes of this study, only 
medical claims and eligibility files containing variables of interest were accessed and a 
subset of data was created containing only these variables (Appendix A).   
Exclusion Criteria.  For those children with gaps in insurance coverage the 
following exclusion criterion was established.  First, those children with less than 6 months 
of continuous insurance coverage were excluded.  Two children from the Medicaid sample 
and five children from the Commercial sample were removed.  Second, the child’s birth year 
and month were examined relative to the 48-month study period January 2007 through 
December 2010.  For example, a child with a birth date of January 2007 would have been 
one month old in Study Month #2 (February 2007).  Next, the child’s age in months was 
examined relative to the gap in insurance coverage.  If a gap in coverage occurred in a month 
when a periodic developmental screening might have taken place (9, 18, 24 or 30 months) 
that child was excluded from the study.  If the gap in insurance coverage appeared one month 
before or after a periodic screening might have taken place, then the child was also excluded.  
A total of 17 additional children (9 Medicaid, 8 Commercial) were excluded using these 
criteria.  To confirm the legitimacy of the diagnostic code for ASD, the code must have 
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appeared at least once in conjunction with a diagnostic office visit to be included in the final 
sample.  Twelve children were excluded from the Commercial sample and 29 children in the 
Medicaid data were excluded from the final sample based on these criteria.  The final sample 
is described in Table 2.1. 
Increasing power.  To increase statistical power the Medicaid and Commercial data 
were merged for all analyses.  The feasibility of merging the subsets of data was examined 
through a Fisher’s Exact Test.  There were no significant differences between the proportion 
of children screened and not screened in the Medicaid and Commercial populations (p = 
0.67; two-tailed) and the variables were identical across the two NH-CHIS data sets.  
However, demographic and socioeconomic differences do exist between these two insured 
populations and results will require clear and cautious interpretation.  The final merged 
sample included 144 children with a diagnosis of ASD (60 Commercial, 84 Medicaid).    
Participant Characteristics  
Table 2.1	  
Comparison Demographics for Medicaid and Commercial Samples n (%) 
 Medicaid 
(n=84) 
Commercial 
(n=60) 
Combined (n=144) 
Gender     
Male 70 (83%) 51 (85%) 121 (84%) 
Female 14 (17%) 9 (15%) 23 (16%) 
Geographic Region     
Urban 65 (77%) 45 (75%) 110 (76%) 
Rural 14 (17%) 5 (8%) 19 (15%) 
Non-NH*  5 (6%) 10 (17%) 15 (10%) 
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Geographic Region.  The sample was further divided based on the geographic region 
in which the child resided.  New Hampshire has ten counties including 5 rural counties that 
account for less than 23% of the total population and 5 urban counties that account for the 
remaining 77%.  For the purposes of this study, this rural/urban distinction was defined such 
that rural counties were those with a population of less than 100,000 and urban counties were 
those with a population greater than 100,000.   
Provider Type.  Thirteen provider types appeared in conjunction with diagnostic 
office visits in the original data.  Provider types were collapsed into 7 categories for the 
regression analyses based on the nature of the services.  For instance, mental health related 
services (psychiatry, psychology, behavioral health) and general medicine (Family Practice, 
Internal Medicine and Physical Medicine) were grouped together.  Pediatric medicine, 
neurology, and Advanced Registered Nurse Practitioner were isolated as unique categories 
(Table 2.2).   
Table 2.2 
Diagnostic Provider Type  (n=143) 
 n (%) 
Pediatric Medicine 37 (25.87) 
Family Practice/General Practice/Internal 
Medicine/Physical Medicine 
23 (16.08) 
Psychiatry/Psychology/Behavioral Health/Social 
Service 
18 (12.58) 
Neurology 27 (18.88) 
Advanced Registered/Nurse Practitioner 11 (7.69) 
Other Professional/Ancillary Provider Laboratory 12 (8.39) 
Acute Care Facility Provider/Ambulatory Health  15 (10.48) 
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Diagnostic codes.  Timing of first ASD diagnosis for each child in the study was 
determined by examining the International Classification of Diseases, Ninth Revision, 
Clinical Modification (ICD-9-CM; 2011) diagnostic codes appearing in the data.  All 
individuals with ICD-9 diagnostic codes of 2990 Infantile Autism, 29900 Infantile Autism-
Active, or 29901 Infantile Autism-Residual (Diagnostic and Statistical Manual of Mental 
Disorders-IV-TR American Psychiatric Association, 2000) were included this study.  The 
diagnostic code for ASD must have appeared at least once in conjunction with a diagnostic 
office visit to be included in the final sample. 
 Procedural codes.  The following Current Procedural Terminology (CPT; American 
Medical Association, 2011) standardized codes were identified to determine when 
developmental screening instruments were utilized. The existence, timing, and frequency of 
CPT codes for developmental screening were examined for each child in the analysis in 
relation to the timing of the first ASD diagnostic code appearing in the data for that child.  
The procedural codes for developmental screening used in this study are listed in Table 2.3. 
Table 2.3 
Current Procedural Terminology (CPT) Codes 
96110 
 Developmental screening, with interpretation and report, per standardized 
instrument form 
96111 
Developmental testing, (includes assessment of motor, language, social, 
adaptive, and/or cognitive functioning by standardized developmental 
instruments) with interpretation and report 
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CPT codes and Healthcare Common Procedure Coding System (HCPCS; Center for 
Medicare and Medicaid Services, 2012) were utilized to determine the type of office visit 
occurring in conjunction with the first use of the ICD-9 diagnostic code for ASD (Table 2.4).   
Table 2.4 
Healthcare Common Procedure Coding System (HCPCS) Codes 
T1024 
Evaluation and Treatment by an integrated, specialty team contracted to 
provide coordinated care to multiply or severely handicapped children 
S0302 Early Periodic Screening, Diagnosis and Treatment Service 
Current Procedural Terminology (CPT) Codes 
99214 
Office or other outpatient visit for the evaluation and management of an 
established patient, which requires at least 2 of these 3 key components: 
A detailed history; A detailed examination; Medical decision making of 
moderate complexity. Counseling and/or coordination of care with other 
providers or agencies are provided consistent with the nature of the 
problem(s) and the patient's and/or family's needs. Usually, the presenting 
problem(s) are of moderate to high severity. Physicians typically spend 
25 minutes face-to-face with the patient and/or family. 
 
Screening Setting.  Setting was examined as a potential variable influencing access 
or timing of screening. While each occurrence of the developmental screening CPT code 
96110 was coded as an office visit (11), no other information on setting was available in the 
data. As a result, only the distinction between office visit and non-office visit could be made.  
Race and ethnicity.  Data on race were unavailable in both subsets of Commercial 
and Medicaid claims.  Ethnicity data were included in the Medicaid claims, but poorly coded 
and difficult to utilize (874,000 of 883,000 member records as unknown in one given month) 
in the Commercial file. Therefore the race and ethnicity variables were removed from the 
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Medicaid data.  Given the homogeneity of New Hampshire’s population (White 93.9%, non-
Hispanic 92.3%) it is unclear how much this variable would contribute to the model.  For 
complete information on race and ethnicity estimates for New Hampshire see Table 1.1  
(United States Census Bureau, 2010). 
Data Analysis Procedures 
 All of the analyses were conducted using SAS v. 9.3 (Cary, NC).    
  Descriptive statistics.  The data were screened to examine all univariate statistics.  
Descriptive statistics for age at diagnosis were calculated, plotted and examined for 
assumptions of normality for children who (a) received developmental screening and 
children who did not and (b) received screening at one time point and those that were 
screened at more than one time point, as well as (c) for each variable in the regression 
analysis (gender, geographic region, and provider type).  Further, age of diagnosis 
comparisons were made by gender, geographic region and provider type.  
 Research question 1.  The first research question addressed differences in age of 
diagnosis when a child did and did not have a screening.  Specifically, the research question 
asked: Are there significant differences in the mean age of ASD diagnosis for those children 
screened and those not screened during well-child visits?  
 Given that the assumption of equal variances was met, an independent groups t-test was 
performed to compare the mean age at diagnosis of ASD for those children screened and 
those children not screened during well-child care, using the PROC TTEST procedure in 
SAS.  The procedure required an examination of the means of the two groups, which 
produced a t-value.  Statistically significant findings would suggest that the use of 
standardized developmental screening tools in well-child care leads to earlier diagnoses of 
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ASD.  A Cohen’s d formula was then used to calculate effect sizes and determine the 
magnitude of the difference in age of diagnosis when a standardized developmental screening 
tool was and was not completed.  The formula for the d was :  
 
where µ1 = the mean age at diagnosis for children who were screened, µ2 = the mean age at 
diagnosis for children who were not screened, and σ = the pooled standard deviation.  
Research question 2.  The second research question further investigated the impact of 
screening by examining the relationship between the number of screenings that were 
completed and age of diagnosis.  The specific research question was: Is there a significant 
difference in the mean age of ASD diagnosis for children who were screened at one time 
point and children who were screened at more than one time point during well-child care? 
After determining that the variances across the two groups were equal, an 
independent groups t-test was performed to compare the mean age at diagnosis of ASD for 
children screened one time and those children screened more than one time during well-child 
care, using the PROC TTEST procedure in SAS.  Again, if the t-value resulted in a p-value 
of less than 0.05 (tdf = X, p > .05), the results were considered statistically significant 
suggesting that the use of standardized developmental screening tools more often in well-
child care leads to earlier diagnoses of ASD.  The magnitude of the difference was 
investigated using a Cohen’s d effect size calculation.  
Research question 3.  The third research question looked at the relationship among a 
number of variables related to age of diagnosis of ASD.  The specific question asked: What 
is the relative strength of the association between gender, geographic region or provider type 
and age at diagnosis of ASD?  To answer the question completely, several follow-up 
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questions were required.  These follow-up questions were:  Given provider type and 
geographic region, what does gender contribute?  Given gender and provider type, what does 
geographic region contribute?  Given geographic region and gender, what does provider type 
contribute?  
 A series of seven multiple linear regression analyses were conducted to examine the 
association between gender (X1), geographic region (X2), and provider type (X3) on age at 
diagnosis of ASD (Y), using the PROC GLM (regression analysis) procedure in SAS.  
Gender and Geographic Region were given binary dummy codes (0,1) in the final analytic 
file.  The seven categories of Provider Type were coded 0 through 6.  Three linear 
regressions were run on each predictor variable (gender, geographic region, provider type) to 
determine the influence of each on age of diagnosis; all possible permutations were run and 
interactions explored. Finally, all variables were entered into the model.  If the summary F-
value resulted in a p-value of less than 0.05, the results were considered statistically 
significant. R2 values were used to report the variation attributable to each parameter in the 
final model and interaction effects were analyzed.  A t-value was estimated for each 
parameter, and its corresponding p-value was used to determine statistical significance.   
  
 
CHAPTER 3 
Results	  
This study examined developmental screening practices for young children with ASD 
in the state of New Hampshire.  The purpose was to understand the relationship between the 
use of screening practices and a number of factors including the age of diagnosis of ASD.  
Data were extracted from the New Hampshire Comprehensive Health Care Information 
System (NH-CHIS) with a final data set including 144 children born between January 1, 
2007 and December 30, 2010. 	  
Descriptive Statistics  
As noted previously, of the 144 participants in this study, 121 (84%) were male and 
23(16%) were female (Table 2.1). The mean age of diagnosis for children in the sample was 
28.97 months (σ2 = 51.07; σ = 7.146) and the range in age of diagnosis was 9-46 months.  
Mean age of diagnosis for girls was slightly lower (µ = 27.77, σ = 6.45) than for boys (µ = 
29.34, σ =7.21).  Figure 3.1 describes gender distribution by geographic region. 
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Figure 3.1
 
 Pediatricians and neurologists conducted the highest frequency of diagnostic office 
visits in the southern region of the state, followed by the Family Practice/General 
Practice/Internal Medicine group and then by Psychiatry/Psychology.  In the northern region 
Pediatricians were most likely to diagnose ASD, followed by Acute Care Physicians, 
Advanced Registered Nurse Practitioners, and then by Family Practice/General 
Practice/Internal Medicine group (Table 3.1).   
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Table 3.1 
 
Frequency of Diagnostic Office Visits by Provider Type and Region n(%) 
 Urban n=109 Rural n=19 Unknown n=16 
Pediatric  26 (23.85) 7 (36.84) 4 (25.00) 
Gen Med 17 (15.59) 2 (10.52) 4 (25.00) 
Beh Med 17 (15.59) 1  (5.26) 1  (6.25) 
Neuro 25 (22.93) 1  (5.26) 1  (6.25) 
ARNP  7 (6.42) 3 (15.78) 1  (6.25) 
Other  9 (8.25) 1  (5.26) 2  (12.50) 
Acute  8 (7.33) 4 (21.05) 3  (18.75) 
 
Twenty-eight children (19%) had CPT code 96110 in their administrative claims file, 
indicating a developmental screening during well child care.  Twenty children (71%) 
received screening in the southern region of the state, 2 (7%) children received screening in 
the northern region, and 6 (21%) children received screening in unreported regions.  Of the 
28 children who received a screening, 16 (57%) received developmental screening at one 
time point and 12 (42%) received screening at more than one time point.  Results are 
reported below relative to the research questions guiding the overall investigation.  
Question 1:  Children screened and not screened during well-child visits 
The initial hypothesis was that children who received developmental screening during 
well-child care would be diagnosed earlier than those who were not screened.  An 
independent groups t-test was used to test for statistically significant differences in mean age 
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of ASD diagnosis for children who received a standardized developmental screening during 
well-child care (n= 28) and those who did not receive a screening (n= 116).  The test of 
Equality of Variances was met and the t-test was performed using the PROC TTEST 
procedure in SAS.  The data suggested no significant differences in mean age of ASD 
diagnosis (t 142= 1.88, p = 0.0968, one-tailed, d=0.3988) for children who received a 
standardized developmental screening during well-child care (µ=26.71, σ =6.92) and those 
who did not (µ=29.51, σ =7.12).  
Question 2:  Children screened at one time point and more than one time point during 
well-child visits 
The second hypothesis was that children who received developmental screening at 
more than one time point would be diagnosed earlier than those who were screened once.  An 
independent groups t-test was used to test for statistically significant differences in mean age 
of ASD diagnosis between children who received a standardized developmental screening at 
one time point (n= 16) and those who received a screening at more than one time point (n= 
12).  The test of Equality of Variances was met (p > 0.0565) and the t-test was performed 
using the PROC TTEST procedure in SAS.  The data showed a statistically significant 
difference (t 24.164= -1.80, p = 0.0415, one-tailed) in mean age of ASD diagnosis for those 
children who received a screening at one time point (µ=24.75, σ =7.92) and those who were 
screened at more than one time point (µ=29.33, σ =4.35).  A Cohen’s d effect size 
calculation was completed indicating a moderate effect size (d=-0.7168; r = -0.337); however, 
the direction of the effect was opposite from the stated hypothesis.  Children who were 
screened at more than one time point were diagnosed later than children screened once.  
	   	    
 47	  
Since this was not part of the stated hypothesis the analysis did not pick up differences at the 
other end of the distribution. 
Question 3:  What is the relative strength of the association between gender, 
geographic region or provider type and age at diagnosis of ASD?   
The third hypothesis was that Gender, Geographic Region, and Provider Type would 
each make unique contributions to timing of ASD diagnoses.  Three linear regressions were 
run on each predictor variable (Gender, Geographic Region, Provider type) to examine the 
extent to which each variable explained individual differences in age of diagnosis using the 
PROC GLM (general linear model) procedure in SAS (Table 3.2).  Neither Gender (Model 1) 
nor Provider Type (Model 3) were independent predictors of age of diagnosis (NS).  
However, Geographic region (Model 2) was statistically significant F(1, 126) = 4.00, p = 
0.04 and accounted for approximately 31% of the variance in age of diagnosis.  
Unexpectedly, mean age of diagnosis was lower in rural regions (µ=27.05, σ =5.62) than 
urban regions of the state (µ=29.70, σ =7.42).  
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Table 3.2  
Predicting Age of ASD Diagnosis: Univariate Models 
 R2 df F t-value p-level 
Model 1      
      Gender 0.007 1 1.06 -1.03 0.304 
Model 2      
      Geographic region 0.307 1 4.00 2.00 0.047* 
Model 3      
      Provider Type 0.019 6 0.45  0.841 
Pediatric Medicine    1.51 0.134 
FP/GP/IntMed/PhysMed    0.99 0.325 
Pyschi/Psychol/BehavHealth    1.04 0.298 
Neurology    1.25 0.211 
ARNP    1.31 0.193 
Other/Ancillary    0.77 0.441 
Acute Care/Amb Care    * * 
*p < 0.05 
A series of 3 linear regressions were performed on all possible permutations to 
examine co-variance among variables (Table 3.3).  For each set of permutations interaction 
effects were examined.  When controlling for Gender (Model 4) and Provider Type (Model 
5), Geographic Region was no longer predictive of age of diagnosis (p = 0.058; p = 0.052 
respectively).   
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Table 3.3  	  
Predicting Age of ASD Diagnosis: Bivariate Models  
 R2 df F t-value p-level 
Model 4 0.046 3 2.03  0.113 
Gender  1 2.40 -0.81 0.123 
Geographic region  1 3.64 1.61 0.058 
Gender X GeoRegion  1 0.04 0.21 0.833 
Model 5 0.084 13 0.81  0.652 
Geographic region  1 3.83 0.694 0.052 
Provider Type  6 0.68  0.670 
Pediatric Medicine    -0.14 0.887 
FP/GP/IntMed/PhysMed    - 0.00 1.00 
Pyschi/Psychol/BehavHea
lth 
     0.06 0.951 
Neurology    - 0.55 0.580 
ARNP    - 0.21 0.833 
Other/Ancillary      0.43 0.667 
Acute Care/Amb Care    _ _ 
GeoRegion X Provider  6 043  0.855 
Model 6 0.097 13 1.07  0.386 
Gender  1 1.01 -1.27 0.316 
Provider Type  6 0.48  0.819 
Pediatric Medicine    1.28 0.202 
FP/GP/IntMed/PhysMed    0.51 0.612 
Pyschi/Psychol/BehavHeal
th 
   0.47 0.639 
Neurology    0.10 0.917 
ARNP    1.39 0.165 
Other/Ancillary    0.35 0.726 
Acute Care/Amb Care    _ _ 
Gender X Provider    1.68  0.132 
*p < 0.05 
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Given geographic region and gender, what does provider type contribute? Given 
provider type and geographic region, what does gender contribute?  Given gender and 
provider type, what does geographic region contribute?   
To address these remaining research questions each variable was entered into the 
model to examine the influence of all three predictor variables on age of diagnosis.   After 
controlling for all variables in the analysis (Model 7), Geographic region was no longer 
significant F (8, 127) = 1.27, p = 0.059.  Although Provider type was not statistically 
significant overall (p=0.653), Pediatric Medicine was approaching significance (p=0.054). 
Table 3.4  	  
Predicting Age of ASD Diagnosis: Full Model 
 R2 df F t-value p-level 
Model 7 0.07 8 1.27  0.264 
Gender  1 2.39  0.124 
Geographic Region  1 3.62  0.059 
Provider Type  6 0.70  0.653 
Pediatric Medicine    1.94 0.054 
FP/GP/IntMed/PhysMed    1.11 0.271 
Pyschi/Psychol/BehavHealth    0.83 0.406 
Neurology    1.20 0.234 
ARNP    1.06 0.290 
Other/Ancillary    1.08 0.281 
Acute Care/Amb Care    _ _ 
*p < 0.05 
 
 
 
 
  
CHAPTER 4 
Discussion 
Young children at risk for ASD are likely to experience early delays in one or more 
domains of development.  Pediatric primary care providers, who see young children at 
regular intervals from birth to three years of age, are well positioned to identify these early 
risk factors.  Better coordination between early childhood professionals and primary care 
providers will ensure that children with ASD risk factors have timely access to early and 
behavioral intervention.  Previous research has demonstrated that young children are three 
times more likely to receive early intervention if a standardized developmental screening tool 
was completed during well-child care (Bethell et al., 2011).   
Universal developmental screening completed during well-child care accelerates the 
path to intervention by detecting delays in development well before a diagnosis of ASD can 
be made.  Therefore, the use of universal developmental screening instruments during well-
child care is critical for young children at risk for ASD.  Yet, prior studies suggest that only 
50%-75% of pediatric primary care providers utilize standardized developmental screening 
instruments (Arunyanart et al., 2012; Sand et al., 2005; Sices et al., 2004).   
The current study examined the frequency of standardized developmental screening 
during well-child care on timing of ASD diagnoses in the state of New Hampshire through 
health care administrative claims data.  Further, the associations between gender, geographic 
region and provider type on mean age of ASD diagnosis were investigated. 
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Rates of Developmental Screening in New Hampshire 
Previous research reported New Hampshire’s rate of standardized developmental 
screening at 18% (How et al., 2011).  In this study, 19% of the children later diagnosed with 
ASD received a standardized developmental screen.  These findings are consistent with 
previous research and suggest relatively low utilization of standardized screening instruments 
in the state.  The high percentage of the study sample living in the southern region of the 
state, which is considered a high-supply physician area (Shipman, et al. 2011), highlights the 
low utilization of screening instruments in the state.  Study of screening utilization rates and 
barriers to developmental screening in New Hampshire may be worthy of further 
investigation. 
Influence of Developmental Screening on Age of Diagnosis 
The hypothesis that children who were screened with a standardized developmental 
screening instrument during well-child care would be diagnosed earlier than those who were 
not screened was not supported by this study.  There were no statistically significant 
differences in mean age of ASD diagnosis for children who received a standardized 
developmental screening during well-child care and those who did not receive a screening.   
There are several potential explanations for these findings. First, only 28 (19%) of the 
144 children in the study had CPT code 96110 in their claims file, reducing the sample size 
and subsequent power of the study.  The results of this analysis were approaching 
significance (p=0.0968) and future studies with a larger sample are warranted.  Second, the 
steps in the referral process are multifaceted and involve intra-office communication, 
communication across disciplines, systems and agencies. In a recent pilot study conducted by 
the AAP (King et al., 2010) monthly referral rates following an at-risk screening averaged 
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only 61% over the 9-month study period and approaches to referral varied widely.  Some 
clinics referred children with a failed screen for diagnostic assessment, some referred for 
private therapy, while still others referred to public early intervention programs, depending 
on the nature and severity of the developmental concern.  Investigating referral practices was 
beyond the scope of the study.  However, further study of referral practices following an ‘at-
risk’ screening in both primary care and the early childhood community is warranted and 
may affect the timing of ASD diagnosis in young children.  Further, examining differences in 
access to early intervention services between children who were screened and not screened 
has implications for future study. 
Frequency of Developmental Screening and Influence on Age of Diagnosis 
The hypothesis that children who received developmental screening at more than one 
time point would be diagnosed earlier than those who were screened at one time point was 
not supported by the data.  The study found statistically significant differences in mean age 
of ASD diagnosis for children who received a screening at one time point (µ=24.75, σ=7.92) 
and those who received screening at more than one time point (µ=29.33, σ=4.35); however, 
the direction of the effect was opposite from the stated hypothesis with mean age of ASD 
diagnosis slightly later for those children who were screened at more than one time point.  
Since this was not part of the stated hypothesis the analysis did not pick up differences at the 
other end of the distribution. 
These findings were unexpected, but upon reflection they are logical.  In this study, 
children who were screened at more than one time point experienced later diagnoses, 
suggesting that providers may have engaged in a period of ‘watchful waiting’ between 
screenings before referring for diagnostic evaluation after a second screen.  These children 
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may have presented a developmental profile with milder developmental delays or unclear 
early markers of ASD, which resulted in later diagnoses.  Previous studies report that 75-80% 
of children with ASD experience co-morbid developmental delays (Sheldrick & Perrin, 
2012), and parents often express concern within the first year (DeGiacomo & Fombonne, 
1997; Ozonoff, 2009).  However, discussions in the literature recommend providers engage 
in periods of ‘watchful waiting’ when concerns arise (Caronna et al., 2007; Ozonoff et al., 
2009) before moving to diagnosis. Due to the nature of administrative claims data, the 
specific results of developmental screenings were unavailable in the current study.  A 
methodology examining the results of developmental screening could indicate the nature of 
first concern during well child care and provide information about the practice of ‘watchful 
waiting’.  Further examination of developmental screening profiles resulting in referral for 
early intervention services may inform future practice.  In addition, the point of referral is a 
critical intersection of service sectors (pediatric primary care and early intervention) 
requiring further examination.  There is strong potential for reciprocity between early 
childhood professionals, who have comprehensive knowledge of child development, and the 
pediatric primary care community that could strengthen the referral process. 
Influence of Gender, Geographic Region and Provider Type on Age of Diagnosis 
The regression analyses tested the extent to which each predictor variable (Gender, 
Geographic Region and Provider Type) explained individual differences in age of diagnosis 
of ASD.   
Gender.  Prior research indicates that males are diagnosed at earlier ages than 
females (Rosenberg et al. 2011; Mandell et al., 2005; Shattuck et al., 2009).  The current 
study hypothesized that gender would be the strongest predictor of age at diagnosis.  This 
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hypothesis was not supported by the data, and may have been affected by the small sample of 
females (23) in the study.  Although these findings were not statistically significant, the mean 
age of diagnosis for girls in the study was slightly lower (µ=27.77, σ =6.45) than for boys 
(µ=29.34, σ =7.21).    
Geographic Region.  The current study hypothesized that mean age of diagnosis 
would be later for children in rural regions of New Hampshire than those in urban regions.  
However, the data did not support this hypothesis.  Geographic region made an independent 
contribution to age of diagnosis, accounting for 31% of the variance when compared to the 
null model.  When controlling for other variables (gender and provider type), geographic 
region no longer made a unique contribution to the model.   
Providers in the northern (more rural) regions of New Hampshire diagnosed ASD 
slightly earlier than providers in southern (more urban) regions of the state. While not 
statistically significant, this was an unexpected finding given the distribution of health care 
providers in the state.  As discussed earlier, northern New Hampshire has primary care 
service areas where provider caseloads exceed 3,000 children (Shipman et al., 2011).  Health 
care providers in this region of the state may have seen children less frequently than 
providers in southern regions.  Given the length of time between visits, it is possible that 
providers in the north may have moved to diagnosis sooner than those in southern regions of 
the state in order to ensure that children would receive timely services.  It is unknown how 
provider caseloads may influence timing of ASD diagnosis, however exploring regional 
differences and the extent to which provider caseloads influence timing of ASD diagnoses 
may be an important implication of this study.   
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Previous studies have suggested disparities in age of diagnosis across geographic 
regions, with children in rural regions receiving later diagnoses than children in urban 
regions (Mandell et al., 2009; Shattuck, 2009).  Using data from the Interactive Autism 
Network database, Rosenberg et al. (2011) reported that geographic region contributed 0.58% 
of the variance in age of diagnosis (n=7871).  Rosenberg et al. (2011) suggest the need for 
initiatives to increase awareness of ASD, promote screening efforts, and increase access to 
early intervention in rural regions of the country. 
Provider Type.  The hypothesis that Provider Type would make a unique 
contribution to the variance of mean age at ASD diagnosis was not supported by this study.  
None of the specified Provider Types contributed unique variance when controlling for other 
variables in the full model (Model 7).  However, in both northern and southern regions of 
New Hampshire pediatricians had the highest frequency of diagnostic office visits and in the 
full model Pediatric Medicine was approaching significance (p=0.054).  Further study with a 
larger sample may provide important information about the influence of Provider Type on 
timing of ASD diagnoses.  To date, there is a gap in the literature on this topic; however, in a 
survey administered by three pediatric practices in New York and New Jersey parents 
reported that a neurologist had assisted them with their child’s diagnosis, while 47% reported 
working with a developmental pediatrician (Harrington, Rosen, Garnecho & Patrick, 2006) . 
Limitations 
 There are several limitations of this study.  First, insurance claims data capture specific 
health care information for those who are insured, but do not capture the experiences of the 
uninsured.  Estimates of public and privately insured and uninsured children (0-18) in New 
Hampshire in 2010 included 78% insured by employer-sponsored or individual (commercial) 
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insurance plans, 18% insured by Medicaid (185% federal poverty level) and 5% uninsured 
(Kaiser Family Foundation, 2012). Socioeconomic and demographic differences in 
populations exist dependent on whether children are insured and type of insurance and results 
must be interpreted with caution. 
 Second, insurance claims data are susceptible to error due to inconsistencies in coding 
across settings and practices.  The CPT code for developmental screening (96110) is 
recommended when an AAP-recommended screening instrument is used; however, even for 
those with insurance, the data may not have accurately captured all children who were 
screened using a standardized tool in New Hampshire during the study period.  Further, it is 
unknown how pediatric providers utilize CPT code 96110 in their practices. Some providers 
prefer to screen children informally during well-child visits and code the visit as a “screening” 
visit (Crais, et al., 2010; unpublished raw data), while others use a standardized tool.  While 
the AAP recommends the use of a standardized developmental screening instrument, the use 
of CPT code 96110 does not guarantee it.  
 Insurance claims data do not provide information about the specific screening 
instruments used or individual results of screening. Children who screened positive but did 
not receive a diagnosis of ASD, and children who received a differential diagnosis (where 
multiple diagnoses were possible) did not appear in these data.  Data on race were 
unavailable, and ethnicity data were poorly coded; therefore the race and ethnicity variables 
were removed from the analyses. Claims data do not include information on severity of 
diagnosis.  Children with more severe symptoms of ASD may have received an earlier 
diagnosis than those with milder expressions of the disorder.   
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Conclusion and Future Implications 
Despite these limitations this study contributes several important findings.  First, the 
mean age of ASD diagnosis in this study was 28.97 months (study period January 2007-
December 2010).  This is consistent with data from the NH Autism Registry, which shows a 
steady decrease in age of ASD diagnosis in the state between 2009 and 2011.  Estimates at 
the national level suggest a mean age of diagnosis between 5 and 6 years.  Thus, these 
preliminary findings are positive indicators that NH is progressing in its ability to identify 
children with ASD early.  Continued examination of this trend with a larger sample will yield 
important information for families and primary care providers in the state. 
Children in this study who were screened at more than one time point experienced 
later diagnoses.  This suggests that these children may have presented with unclear 
developmental profiles leading providers to engage in a period of ‘watchful waiting’ between 
screenings and potentially delaying access to early intervention.  A methodology comparing 
developmental screening profiles resulting in referral for early intervention with those that 
did not warrant referral could provide information about the practice of ‘watchful waiting’ 
and inform future efforts to identify children at risk for ASD at earlier ages.   
In this study, geographic region made an independent contribution to timing of ASD 
diagnosis, accounting for 31% of the variance. Providers in northern regions of NH 
diagnosed children with ASD at slightly younger ages than those in southern regions and 
pediatricians in the study had the highest frequency of diagnostic office visits when 
compared to other provider types.  Continued examination of regional differences in timing 
of ASD diagnoses by provider type is an important implication of this study.   
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For young children at risk for ASD the full year between 12 and 24 months requires 
especially close surveillance as early behavioral markers of ASD emerge during this time 
period (Baranek, 1999; Colgan et al., 2006; Zwaigenbaum, 2005); however, there is only one 
scheduled well-child visit (18 months) during this critical period.  If a child at-risk for ASD 
misses the 18-month visit, then the potential for intervention is delayed.  In addition, 
redundancies across the three sets of screening guidelines for children with developmental 
and behavioral disorders (AAP, 2006; AAP, 2007; AAP, 2010) have been identified and an 
alignment of screening and surveillance algorithms has been suggested (Marks et al., 2011).  
Other future directions include (1) examining timing of well-child visits for children with 
developmental risk factors, and (2) examining the role of parents in the developmental 
screening process, especially if they have a concern about their child.   
Although beyond the scope of this study, administrative claims data contain information 
about related services (early intervention) received.  A future study examining timing of early 
intervention services in relation to ASD diagnoses in NH has the potential to further inform 
practice. Continued efforts to measure screening practices through use of administrative 
claims data has the potential to increase utilization of developmental screening instruments 
and improve access to early intervention for young children with ASD. 	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Appendix A 
Variables included in analysis 
Study person identification A unique numerical identifier randomly 
assigned by Institute for Health Policy and 
Practice 
Relative birth month Birth month/year relative to study 
month/year 
Birthdates  Year and month of child’s birth 
Date_service_from Dates of service provided 
Date_service_to Dates of service provided 
Gender Categorical variable  
County County name (10 counties in NH)  
Geographic region* A dichotomous variable was created to 
define two geographic groups (urban and 
rural) by examining population estimates 
across the ten counties in New Hampshire.   
Insurance eligibility  Categorical variable appearing in data by 
month  
Provider specialty code Provider Type 
Procedural code CPT, ICD-9, HCPCS Code 
*Indicates a variable created for this analysis 
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